Rosuvastatin (Crestor) reduces LDL by up to 63% and was the first statin shown to cause plaque regression (ASTEROID trial). The JUPITER trial demonstrated cardiovascular event reduction in patients with elevated CRP but normal LDL.
Research summaries are AI-generated from open-access peer-reviewed literature (PubMed Central, Cochrane, AHA/ACC). Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.